BioCatalystWatch
ALKSWorkspace / ALKS / OverviewCompany library
Price
Market cap
Next catalyst4Q 2026Alixorexton — Vibrance-3 · Study completionCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

OX2R

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ALKS 7290

OX2R

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

ALKS 4510

Orexin 2 receptor (OX2R)

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

OX2R

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ALKS 4510

Orexin 2 receptor (OX2R)

Upcoming / outlook

  • Timing and evidence

ALKS 7290

OX2R

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

LUMRYZ

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ALKS 7290

OX2R

PreINDP1P2P3FilingApproved
ALKS 1140

HDAC

PreINDP1P2P3FilingApproved
HIIP

PreINDP1P2P3FilingApproved

Approved / commercial

LUMRYZ

Approved

PreINDP1P2P3FilingApproved
LYBALVI

Opioid receptors

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

LYBALVI

Opioid receptors

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Opioid receptor

Approved

PreINDP1P2P3FilingApproved

Opioid receptor

Approved

PreINDP1P2P3FilingApproved

History / paused

Intermediate-affinity IL-2 receptor complex

PreINDP1P2P3FilingApproved

Intermediate-affinity IL-2 receptor complex

PreINDP1P2P3FilingApproved

Intermediate-affinity IL-2 receptor complex

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ALKS PR & News

PR & News

ALKS SEC archive